Silence Therapeutics plc Current Tax Expense Income
Silence Therapeutics plc (SLN) reported Current Tax Expense Income of -GBP 7.03 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxExpenseIncome · last filed 2024-03-13
| Period end | Current Tax Expense Income 12 month | Current Tax Expense Income 12 month as first filed |
|---|---|---|
| 2023-12-31 | -7.03M GBP 20-F · filed 2024-03-13 | |
| 2022-12-31 | -7.28M GBP 20-F · filed 2024-03-13 | |
| 2021-12-31 | -5.57M GBP 20-F · filed 2023-03-15 | -6.40M GBP 20-F · filed 2022-03-17 |